It has been demonstrated that in cancer cells, activation of hepatocyte growth factor receptor (HGFR, also known as MET), human epidermal growth factor receptor 2 (HER2, also known as ERBB2), and tyrosine kinases stimulates cortactin phosphorylation [81]. This evidence concerns the gene CTTN and cancer.